Literature DB >> 3411197

Glutathione concentrations in rat lung bronchoalveolar lavage fluid: effects of hyperoxia.

S G Jenkinson1, R D Black, R A Lawrence.   

Abstract

Glutathione concentrations were measured in rat bronchoalveolar lavage fluid (BALF) obtained from normal rats and rats exposed to a fraction of inspired oxygen (FiO2) of 0.8 for up to 5 days. We also perturbed rat lung glutathione concentrations by administering the compound diisopropylidene acetone (phorone) to a separate group of animals and correlated changes in BALF glutathione with changes in lung tissue glutathione. We found that reduced glutathione is present in normal rat BALF but glutathione disulfide is extremely low. Increases in lung tissue glutathione concentration and in BALF glutathione concentration occurred after 5 days of exposure to hyperoxia. Animals treated with phorone exhibited decreases in lung glutathione concentration two hours after dosing and increases in lung glutathione concentration 24 hours after dosing. Rat BALF obtained from phorone-treated animals at 2 or 24 hours after administration revealed that changes in BALF glutathione concentrations reflected changes in lung tissue glutathione concentration. The presence of glutathione in lung lavage fluid suggests that the compound could be playing an extracellular role in the lung, either as an antioxidant or as a coenzyme for other glutathione-related enzymatic reactions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3411197

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

Review 1.  Toxic oxidant species and their impact on the pulmonary surfactant system.

Authors:  E Putman; L M van Golde; H P Haagsman
Journal:  Lung       Date:  1997       Impact factor: 2.584

2.  Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity.

Authors:  M Linden; L Håkansson; K Ohlsson; K Sjödin; H Tegner; A Tunek; P Venge
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

3.  Frequent paracetamol use and asthma in adults.

Authors:  S O Shaheen; J A Sterne; C E Songhurst; P G Burney
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

Review 4.  Racing against time: leveraging preclinical models to understand pulmonary susceptibility to perinatal acetaminophen exposures.

Authors:  David J McCulley; Erik A Jensen; Jennifer M S Sucre; Sarah McKenna; Laura G Sherlock; Evgenia Dobrinskikh; Clyde J Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-05-03       Impact factor: 6.011

5.  Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine.

Authors:  M M Bridgeman; M Marsden; W MacNee; D C Flenley; A P Ryle
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

Review 6.  Lung oxidative damage by hypoxia.

Authors:  O F Araneda; M Tuesta
Journal:  Oxid Med Cell Longev       Date:  2012-08-26       Impact factor: 6.543

7.  BN 52021 (a platelet activating factor-receptor antagonist) decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis.

Authors:  J L Pérez-Arellano; T Martín; J M López-Novoa; M L Sánchez; A Montero; A Jiménez
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

Review 8.  Glutathione and inflammatory disorders of the lung.

Authors:  A M Cantin; R Bégin
Journal:  Lung       Date:  1991       Impact factor: 2.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.